Michele Cafone is a New York, New York based nurse practitioner. Active license number of Michele Cafone is 382684 for Pediatrics in New York. Her current practice location is 1468 Madison Ave, New York. Patients can reach her at 212-241-8662. Michele Cafone is PNP and her NPI number (Unique professional ID assigned by NPPES) is 1174060313. Michele Cafone has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Michele Cafone speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1174060313
NPI Enumeration Date:
26 Jan, 2017
NPI Last Update On:
26 Jan, 2017
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Michele Cafone are as mentioned below.
License Number
Specialization
State
Status
382684
Pediatrics
New York
Primary
646842
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Michele Cafone 29 Spencer Dr, Morristown, New Jersey
Zip:
07960-3539
Phone Number:
973-652-5225
Patients can reach Michele Cafone at 1468 Madison Ave, New York, New York or can call to book an appointment on 212-241-8662.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.